Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

O. Caffo, G. Facchini, E. Biasco, F. Ferraù, F. Morelli, M. Donini, C. Buttigliero, N. Calvani, A. Guida, V.E. Chiuri, U. Basso, C. Mucciarini, V. Conteduca, S. Rossetti, A. Veccia, F. Maines, S. Kinspergher, U.D. Giorgi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1115-1123
Number of pages9
JournalFuture Oncology
Volume15
Issue number10
DOIs
Publication statusPublished - 2019

Cite this

Caffo, O., Facchini, G., Biasco, E., Ferraù, F., Morelli, F., Donini, M., Buttigliero, C., Calvani, N., Guida, A., Chiuri, V. E., Basso, U., Mucciarini, C., Conteduca, V., Rossetti, S., Veccia, A., Maines, F., Kinspergher, S., & Giorgi, U. D. (2019). Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer. Future Oncology, 15(10), 1115-1123. https://doi.org/10.2217/fon-2018-0715